COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-30

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current management of VID-19 consists of oxygen support without specific treatment. Hospitalization may suddenly require delayed resuscitation. This evolution corresponds to an atypical acute respiratory distress syndrome (ARDS), the mechanism of which is poorly understood and difficult to predict. The general pathophysiology of ARDS, the vascular tropism of SARS-Cov2, the description of coagulopathy and numerous pulmonary artery thromboses in resuscitation and the encouraging investigation of antithrombotics in general ARDS

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19

NCT04347928

COVID-19 ARDS Sars-CoV2

COMPLETED

ARDS Caused by COVID-19

NCT04368975

Acute Respiratory Failure With Hypoxia

UNKNOWN

Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)

NCT05092737

ARDS Sars-CoV-2 Infection

COMPLETED

Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS

NCT04350710

Acute Respiratory Distress Syndrome COVID

UNKNOWN

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

NCT04343404

Respiratory Distress Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sars-CoV2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major Subject (≥18 years)
* Subject hospitalised in HUS or GHRMSA for COVID-19
* The diagnosis COVID-19 confirmed by smear or evoked by CT scan or chest X-ray without a differential diagnosis retained in the medical record
* Subjects who, after being informed, do not wish to have their data reused for the purposes of this research

Exclusion Criteria

* Subject who expressed opposition to participating in the study
* Subject under guardianship or trusteeship
* Subject under safeguard of justice
* Patient hospitalized in a geriatric service or in a ward not labeled COVID (surgery, oncology,...) or in a short-term hospitalization unit without transfer to another service.
* Serious patient on admission to the emergency room and recused from resuscitation.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No